VMD-102 / VM Discovery - LARVOL DELTA

Pro-KCEI: A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors (clinicaltrials.gov) - P1/2 | N=111 | Recruiting | Sponsor: VM Discovery, Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Colorectal Cancer • Eye Cancer • Genito-urinary Cancer • Hepatocellular Cancer • Lung Cancer • Melanoma • Non Small Cell Lung Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor • Uveal Melanoma

Pro-KCEI: A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors (clinicaltrials.gov) - P1/2 | N=111 | Not yet recruiting | Sponsor: VM Discovery, Inc.

First-in-human • New P1/2 trial • Colorectal Cancer • Eye Cancer • Genito-urinary Cancer • Hepatocellular Cancer • Lung Cancer • Melanoma • Non Small Cell Lung Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor • Uveal Melanoma